Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Stringent regulations regarding safety and quality
3.2.1.2 Increasing demand for biopharmaceuticals
3.2.1.3 Rising R&D expenditure in life sciences sector
3.2.1.4 Increasing demand for bioprocess validation outsourcing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complexity and time-intensive nature of validation
3.2.2.2 High costs associated with validation processes
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Testing Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Extractables/leachables testing
5.3 Microbiological testing
5.4 Integrity testing
5.5 Viral clearance testing
5.6 Adventitious agent testing
5.7 Mycoplasma testing
5.8 Physiochemical testing
5.9 Compatibility testing
5.10 Other testing types
Chapter 6 Market Estimates and Forecast, By Stage, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Process design
6.3 Process qualification
6.4 Continued process verification
Chapter 7 Market Estimates and Forecast, By Mode, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 In-house
7.3 Outsourced
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Biopharmaceuticals
8.3 Gene and cell therapy
8.4 Vaccines
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical companies
9.3 Biotechnology companies
9.4 CROs and CDMOs
9.5 Academic and research institutes
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Asahi Kasei Corporation
11.2 Bio-Rad Laboratories
11.3 Charles River Laboratories
11.4 Danaher Corporation
11.5 Eurofins Scientific
11.6 Lonza Group
11.7 Meissner Filtration Products
11.8 Merck KGaA
11.9 Pace Analytical Services
11.10 Repligen Corporation
11.11 Sartorius AG
11.12 SGS S.A.
11.13 Thermo Fisher Scientific
11.14 Tosoh Corporation
11.15 WuXi AppTec
